These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 3463439

  • 1. Apparent mineralocorticoid excess causing hypertension and hypokalemia in children.
    New MI, Stoner E, DiMartino-Nardi J.
    Clin Exp Hypertens A; 1986; 8(4-5):751-72. PubMed ID: 3463439
    [Abstract] [Full Text] [Related]

  • 2. New findings in apparent mineralocorticoid excess.
    DiMartino-Nardi J, Stoner E, Martin K, Balfe JW, Jose PA, New MI.
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
    [Abstract] [Full Text] [Related]

  • 3. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T, Al-Shaikh A.
    J Pediatr Endocrinol Metab; 2012 Jul; 25(11-12):1083-8. PubMed ID: 23329753
    [Abstract] [Full Text] [Related]

  • 4. Apparent mineralocorticoid excess syndromes.
    Shimojo M, Stewart PM.
    J Endocrinol Invest; 1995 Jul; 18(7):518-32. PubMed ID: 9221270
    [Abstract] [Full Text] [Related]

  • 5. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
    Stewart PM, Walker BR, Holder G, O'Halloran D, Shackleton CH.
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
    [Abstract] [Full Text] [Related]

  • 6. 11 beta-Hydroxysteroid dehydrogenase deficit: a rare cause of arterial Hypertension. Diagnosis and therapeutic approach in two young brothers.
    Gourmelen M, Saint-Jacques I, Morineau G, Soliman H, Julien R, Fiet J.
    Eur J Endocrinol; 1996 Aug; 135(2):238-44. PubMed ID: 8810740
    [Abstract] [Full Text] [Related]

  • 7. [Syndrome of apparent mineralocorticoid excess caused by a deficiency of 11 beta-hydroxysteroid dehydrogenase: clinical and genetic study in a Chilean family followed for 19 years].
    Rodríguez JA.
    Rev Med Chil; 2000 Jan; 128(1):17-26. PubMed ID: 10883518
    [Abstract] [Full Text] [Related]

  • 8. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM, Corrie JE, Shackleton CH, Edwards CR.
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [Abstract] [Full Text] [Related]

  • 9. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome?
    Palermo M, Delitala G, Sorba G, Cossu M, Satta R, Tedde R, Pala A, Shackleton CH.
    J Endocrinol Invest; 2000 Jul; 23(7):457-62. PubMed ID: 11005270
    [Abstract] [Full Text] [Related]

  • 10. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
    Oberfield SE, Levine LS, Carey RM, Greig F, Ulick S, New MI.
    J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
    [Abstract] [Full Text] [Related]

  • 11. Steroid hormones and hypertension: the cortisol-cortisone shuttle.
    Stewart PM, Whorwood CB, Walker BR.
    Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018
    [Abstract] [Full Text] [Related]

  • 12. Apparent mineralocorticoid excess: type I and type II.
    Mantero F, Palermo M, Petrelli MD, Tedde R, Stewart PM, Shackleton CH.
    Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999
    [Abstract] [Full Text] [Related]

  • 13. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC, Mune T, Rogerson FM, Kayes KM, Agarwal AK.
    Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285
    [Abstract] [Full Text] [Related]

  • 14. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G, Pascoe L, Marc JM, Caillette A, Krozowski Z, Corvol P, Fiet J.
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [Abstract] [Full Text] [Related]

  • 15. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
    Palermo M, Shackleton CH, Mantero F, Stewart PM.
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
    [Abstract] [Full Text] [Related]

  • 16. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A, Dick B, Arnold P, Zaehner T, Plueschke V, Deregibus MN, Repetto H, Frey BM, Frey FJ, Ferrari P.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
    [Abstract] [Full Text] [Related]

  • 17. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess.
    Speiser PW, Riddick LM, Martin K, New MI.
    Metabolism; 1993 Jul; 42(7):843-5. PubMed ID: 8393954
    [Abstract] [Full Text] [Related]

  • 18. Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess.
    Milford DV, Shackleton CH, Stewart PM.
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):241-6. PubMed ID: 7554322
    [Abstract] [Full Text] [Related]

  • 19. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess.
    White PC.
    Am J Med Sci; 2001 Dec; 322(6):308-15. PubMed ID: 11780688
    [Abstract] [Full Text] [Related]

  • 20. The syndrome of apparent mineralocorticoid excess.
    Cooper M, Stewart PM.
    QJM; 1998 Jul; 91(7):453-5. PubMed ID: 9797927
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.